A High Stakes Showdown: Cronos CEO Takes Aim at Short Seller Andrew Left The trial of Citron Research founder Andrew Left has taken an unexpected turn, as the CEO of Canadian cannabis distributor Cronos Group testified that he was left reeling by a scathing report from the short seller.
The drama unfolding in the US District Court for the Central District of California is not just a matter of one company's fortunes; it speaks to the ongoing tensions between short sellers and the companies they target.
The CEO recounted his surprise at Andrew Left's report, which sent shares plummeting.